Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative

The relationship between systolic blood pressure (SBP) and longevity is not fully understood. We aimed to determine which SBP levels in women ≥65 years of age with or without blood pressure medication were associated with the highest probability of surviving to 90 years of age. The study population...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2024-05, Vol.149 (20), p.1568-1577
Hauptverfasser: Haring, Bernhard, Andrews, Chris A, Hovey, Kathleen, Shadyab, Aladdin H, LaCroix, Andrea, Martin, Lisa Warsinger, Rosal, Milagros C, Kuller, Lewis H, Salmoirago-Blotcher, Elena, Saquib, Nazmus, Koo, Patrick, Laddu, Deepika, Stefanick, Marcia L, Manson, JoAnn E, Wassertheil-Smoller, Sylvia, LaMonte, Michael J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1577
container_issue 20
container_start_page 1568
container_title Circulation (New York, N.Y.)
container_volume 149
creator Haring, Bernhard
Andrews, Chris A
Hovey, Kathleen
Shadyab, Aladdin H
LaCroix, Andrea
Martin, Lisa Warsinger
Rosal, Milagros C
Kuller, Lewis H
Salmoirago-Blotcher, Elena
Saquib, Nazmus
Koo, Patrick
Laddu, Deepika
Stefanick, Marcia L
Manson, JoAnn E
Wassertheil-Smoller, Sylvia
LaMonte, Michael J
description The relationship between systolic blood pressure (SBP) and longevity is not fully understood. We aimed to determine which SBP levels in women ≥65 years of age with or without blood pressure medication were associated with the highest probability of surviving to 90 years of age. The study population consisted of 16570 participants enrolled in the Women's Health Initiative who were eligible to survive to 90 years of age by February 28, 2020, without a history of cardiovascular disease, diabetes, or cancer. Blood pressure was measured at baseline (1993 through 1998) and then annually through 2005. The outcome was defined as survival to 90 years of age with follow-up. Absolute probabilities of surviving to 90 years of age were estimated for all combinations of SBP and age using generalized additive logistic regression modeling. The SBP that maximized survival was estimated for each age, and a 95% CI was generated. During a median follow-up of 19.8 years, 9723 of 16 570 women (59%) survived to 90 years of age. Women with an SBP between 110 and 130 mm Hg at attained ages of 65, 70, 75, and 80 years had a 38% (95% CI, 34%-48%), 54% (52%-56%), 66% (64%-67%), or 75% (73%-78%) absolute probability to survive to 90 years of age, respectively. The probability of surviving to 90 years of age was lower for greater SBP levels. Women at the attained age of 80 years with 0%, 20%, 40%, 60%, 80%, or 100% time in therapeutic range (defined as an SBP between 110 and 130 mm Hg) had a 66% (64%-69%), 68% (67%-70%), 71% (69%-72%), 73% (71%-74%), 75% (72%-77%), or 77% (74%-79%) absolute survival probability to 90 years of age. For women >65 years of age with low cardiovascular disease and other chronic disease risk, an SBP level
doi_str_mv 10.1161/CIRCULATIONAHA.123.067302
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3039806025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3039806025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-578ebfa0a74c9bc212339a2d919e7228dc4009cec738481ed87288018ac4c8043</originalsourceid><addsrcrecordid>eNpVkEtPwzAQhC0EoqXwF5A5wSXFjyR2uIUIaKWKopbHMbjOFoKcuthOpf57ggpInFYrzczufAidUTKkNKWXxXhWPE3yx_H0Ph_lQ8r4kKSCE7aH-jRhcRQnPNtHfUJIFgnOWA8def_RrSkXySHqcZkyLlLaR6_zrQ_W1BpfG2sr_ODA-9YBVqsKz1u3qTfK4GDxM7gtnpoK529whWfgWxM8vnW2weEd8IttYHXu8QiUCe94vKpDrUK9gWN0sFTGw8nPHKCn25vHYhRNpnfjIp9EmlMWokRIWCwVUSLW2UKzrhPPFKsymoFgTFY67spo0ILLWFKopGBSEiqVjrUkMR-gi13u2tnPFnwom9prMEatwLa-5IRnkqSEJZ0020m1s947WJZrVzfKbUtKym_A5X_AZfdMuQPceU9_zrSLBqo_5y9R_gXZiXdv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3039806025</pqid></control><display><type>article</type><title>Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative</title><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><creator>Haring, Bernhard ; Andrews, Chris A ; Hovey, Kathleen ; Shadyab, Aladdin H ; LaCroix, Andrea ; Martin, Lisa Warsinger ; Rosal, Milagros C ; Kuller, Lewis H ; Salmoirago-Blotcher, Elena ; Saquib, Nazmus ; Koo, Patrick ; Laddu, Deepika ; Stefanick, Marcia L ; Manson, JoAnn E ; Wassertheil-Smoller, Sylvia ; LaMonte, Michael J</creator><creatorcontrib>Haring, Bernhard ; Andrews, Chris A ; Hovey, Kathleen ; Shadyab, Aladdin H ; LaCroix, Andrea ; Martin, Lisa Warsinger ; Rosal, Milagros C ; Kuller, Lewis H ; Salmoirago-Blotcher, Elena ; Saquib, Nazmus ; Koo, Patrick ; Laddu, Deepika ; Stefanick, Marcia L ; Manson, JoAnn E ; Wassertheil-Smoller, Sylvia ; LaMonte, Michael J</creatorcontrib><description>The relationship between systolic blood pressure (SBP) and longevity is not fully understood. We aimed to determine which SBP levels in women ≥65 years of age with or without blood pressure medication were associated with the highest probability of surviving to 90 years of age. The study population consisted of 16570 participants enrolled in the Women's Health Initiative who were eligible to survive to 90 years of age by February 28, 2020, without a history of cardiovascular disease, diabetes, or cancer. Blood pressure was measured at baseline (1993 through 1998) and then annually through 2005. The outcome was defined as survival to 90 years of age with follow-up. Absolute probabilities of surviving to 90 years of age were estimated for all combinations of SBP and age using generalized additive logistic regression modeling. The SBP that maximized survival was estimated for each age, and a 95% CI was generated. During a median follow-up of 19.8 years, 9723 of 16 570 women (59%) survived to 90 years of age. Women with an SBP between 110 and 130 mm Hg at attained ages of 65, 70, 75, and 80 years had a 38% (95% CI, 34%-48%), 54% (52%-56%), 66% (64%-67%), or 75% (73%-78%) absolute probability to survive to 90 years of age, respectively. The probability of surviving to 90 years of age was lower for greater SBP levels. Women at the attained age of 80 years with 0%, 20%, 40%, 60%, 80%, or 100% time in therapeutic range (defined as an SBP between 110 and 130 mm Hg) had a 66% (64%-69%), 68% (67%-70%), 71% (69%-72%), 73% (71%-74%), 75% (72%-77%), or 77% (74%-79%) absolute survival probability to 90 years of age. For women &gt;65 years of age with low cardiovascular disease and other chronic disease risk, an SBP level &lt;130 mm Hg was found to be associated with longevity. These findings reinforce current guidelines targeting an SBP target &lt;130 mm Hg in older women.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.123.067302</identifier><identifier>PMID: 38623761</identifier><language>eng</language><publisher>United States</publisher><ispartof>Circulation (New York, N.Y.), 2024-05, Vol.149 (20), p.1568-1577</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c312t-578ebfa0a74c9bc212339a2d919e7228dc4009cec738481ed87288018ac4c8043</cites><orcidid>0000-0003-4636-8698 ; 0000-0003-4352-0914 ; 0000-0002-9532-976X ; 0009-0005-6335-760X ; 0000-0002-8482-1353 ; 0000-0001-5130-6374 ; 0000-0001-6109-431X ; 0000-0002-0284-6996 ; 0000-0001-6790-0220 ; 0000-0002-9426-7595 ; 0000-0002-6669-5242 ; 0000-0002-2819-2839</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38623761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haring, Bernhard</creatorcontrib><creatorcontrib>Andrews, Chris A</creatorcontrib><creatorcontrib>Hovey, Kathleen</creatorcontrib><creatorcontrib>Shadyab, Aladdin H</creatorcontrib><creatorcontrib>LaCroix, Andrea</creatorcontrib><creatorcontrib>Martin, Lisa Warsinger</creatorcontrib><creatorcontrib>Rosal, Milagros C</creatorcontrib><creatorcontrib>Kuller, Lewis H</creatorcontrib><creatorcontrib>Salmoirago-Blotcher, Elena</creatorcontrib><creatorcontrib>Saquib, Nazmus</creatorcontrib><creatorcontrib>Koo, Patrick</creatorcontrib><creatorcontrib>Laddu, Deepika</creatorcontrib><creatorcontrib>Stefanick, Marcia L</creatorcontrib><creatorcontrib>Manson, JoAnn E</creatorcontrib><creatorcontrib>Wassertheil-Smoller, Sylvia</creatorcontrib><creatorcontrib>LaMonte, Michael J</creatorcontrib><title>Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>The relationship between systolic blood pressure (SBP) and longevity is not fully understood. We aimed to determine which SBP levels in women ≥65 years of age with or without blood pressure medication were associated with the highest probability of surviving to 90 years of age. The study population consisted of 16570 participants enrolled in the Women's Health Initiative who were eligible to survive to 90 years of age by February 28, 2020, without a history of cardiovascular disease, diabetes, or cancer. Blood pressure was measured at baseline (1993 through 1998) and then annually through 2005. The outcome was defined as survival to 90 years of age with follow-up. Absolute probabilities of surviving to 90 years of age were estimated for all combinations of SBP and age using generalized additive logistic regression modeling. The SBP that maximized survival was estimated for each age, and a 95% CI was generated. During a median follow-up of 19.8 years, 9723 of 16 570 women (59%) survived to 90 years of age. Women with an SBP between 110 and 130 mm Hg at attained ages of 65, 70, 75, and 80 years had a 38% (95% CI, 34%-48%), 54% (52%-56%), 66% (64%-67%), or 75% (73%-78%) absolute probability to survive to 90 years of age, respectively. The probability of surviving to 90 years of age was lower for greater SBP levels. Women at the attained age of 80 years with 0%, 20%, 40%, 60%, 80%, or 100% time in therapeutic range (defined as an SBP between 110 and 130 mm Hg) had a 66% (64%-69%), 68% (67%-70%), 71% (69%-72%), 73% (71%-74%), 75% (72%-77%), or 77% (74%-79%) absolute survival probability to 90 years of age. For women &gt;65 years of age with low cardiovascular disease and other chronic disease risk, an SBP level &lt;130 mm Hg was found to be associated with longevity. These findings reinforce current guidelines targeting an SBP target &lt;130 mm Hg in older women.</description><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkEtPwzAQhC0EoqXwF5A5wSXFjyR2uIUIaKWKopbHMbjOFoKcuthOpf57ggpInFYrzczufAidUTKkNKWXxXhWPE3yx_H0Ph_lQ8r4kKSCE7aH-jRhcRQnPNtHfUJIFgnOWA8def_RrSkXySHqcZkyLlLaR6_zrQ_W1BpfG2sr_ODA-9YBVqsKz1u3qTfK4GDxM7gtnpoK529whWfgWxM8vnW2weEd8IttYHXu8QiUCe94vKpDrUK9gWN0sFTGw8nPHKCn25vHYhRNpnfjIp9EmlMWokRIWCwVUSLW2UKzrhPPFKsymoFgTFY67spo0ILLWFKopGBSEiqVjrUkMR-gi13u2tnPFnwom9prMEatwLa-5IRnkqSEJZ0020m1s947WJZrVzfKbUtKym_A5X_AZfdMuQPceU9_zrSLBqo_5y9R_gXZiXdv</recordid><startdate>20240514</startdate><enddate>20240514</enddate><creator>Haring, Bernhard</creator><creator>Andrews, Chris A</creator><creator>Hovey, Kathleen</creator><creator>Shadyab, Aladdin H</creator><creator>LaCroix, Andrea</creator><creator>Martin, Lisa Warsinger</creator><creator>Rosal, Milagros C</creator><creator>Kuller, Lewis H</creator><creator>Salmoirago-Blotcher, Elena</creator><creator>Saquib, Nazmus</creator><creator>Koo, Patrick</creator><creator>Laddu, Deepika</creator><creator>Stefanick, Marcia L</creator><creator>Manson, JoAnn E</creator><creator>Wassertheil-Smoller, Sylvia</creator><creator>LaMonte, Michael J</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4636-8698</orcidid><orcidid>https://orcid.org/0000-0003-4352-0914</orcidid><orcidid>https://orcid.org/0000-0002-9532-976X</orcidid><orcidid>https://orcid.org/0009-0005-6335-760X</orcidid><orcidid>https://orcid.org/0000-0002-8482-1353</orcidid><orcidid>https://orcid.org/0000-0001-5130-6374</orcidid><orcidid>https://orcid.org/0000-0001-6109-431X</orcidid><orcidid>https://orcid.org/0000-0002-0284-6996</orcidid><orcidid>https://orcid.org/0000-0001-6790-0220</orcidid><orcidid>https://orcid.org/0000-0002-9426-7595</orcidid><orcidid>https://orcid.org/0000-0002-6669-5242</orcidid><orcidid>https://orcid.org/0000-0002-2819-2839</orcidid></search><sort><creationdate>20240514</creationdate><title>Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative</title><author>Haring, Bernhard ; Andrews, Chris A ; Hovey, Kathleen ; Shadyab, Aladdin H ; LaCroix, Andrea ; Martin, Lisa Warsinger ; Rosal, Milagros C ; Kuller, Lewis H ; Salmoirago-Blotcher, Elena ; Saquib, Nazmus ; Koo, Patrick ; Laddu, Deepika ; Stefanick, Marcia L ; Manson, JoAnn E ; Wassertheil-Smoller, Sylvia ; LaMonte, Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-578ebfa0a74c9bc212339a2d919e7228dc4009cec738481ed87288018ac4c8043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haring, Bernhard</creatorcontrib><creatorcontrib>Andrews, Chris A</creatorcontrib><creatorcontrib>Hovey, Kathleen</creatorcontrib><creatorcontrib>Shadyab, Aladdin H</creatorcontrib><creatorcontrib>LaCroix, Andrea</creatorcontrib><creatorcontrib>Martin, Lisa Warsinger</creatorcontrib><creatorcontrib>Rosal, Milagros C</creatorcontrib><creatorcontrib>Kuller, Lewis H</creatorcontrib><creatorcontrib>Salmoirago-Blotcher, Elena</creatorcontrib><creatorcontrib>Saquib, Nazmus</creatorcontrib><creatorcontrib>Koo, Patrick</creatorcontrib><creatorcontrib>Laddu, Deepika</creatorcontrib><creatorcontrib>Stefanick, Marcia L</creatorcontrib><creatorcontrib>Manson, JoAnn E</creatorcontrib><creatorcontrib>Wassertheil-Smoller, Sylvia</creatorcontrib><creatorcontrib>LaMonte, Michael J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haring, Bernhard</au><au>Andrews, Chris A</au><au>Hovey, Kathleen</au><au>Shadyab, Aladdin H</au><au>LaCroix, Andrea</au><au>Martin, Lisa Warsinger</au><au>Rosal, Milagros C</au><au>Kuller, Lewis H</au><au>Salmoirago-Blotcher, Elena</au><au>Saquib, Nazmus</au><au>Koo, Patrick</au><au>Laddu, Deepika</au><au>Stefanick, Marcia L</au><au>Manson, JoAnn E</au><au>Wassertheil-Smoller, Sylvia</au><au>LaMonte, Michael J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2024-05-14</date><risdate>2024</risdate><volume>149</volume><issue>20</issue><spage>1568</spage><epage>1577</epage><pages>1568-1577</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><abstract>The relationship between systolic blood pressure (SBP) and longevity is not fully understood. We aimed to determine which SBP levels in women ≥65 years of age with or without blood pressure medication were associated with the highest probability of surviving to 90 years of age. The study population consisted of 16570 participants enrolled in the Women's Health Initiative who were eligible to survive to 90 years of age by February 28, 2020, without a history of cardiovascular disease, diabetes, or cancer. Blood pressure was measured at baseline (1993 through 1998) and then annually through 2005. The outcome was defined as survival to 90 years of age with follow-up. Absolute probabilities of surviving to 90 years of age were estimated for all combinations of SBP and age using generalized additive logistic regression modeling. The SBP that maximized survival was estimated for each age, and a 95% CI was generated. During a median follow-up of 19.8 years, 9723 of 16 570 women (59%) survived to 90 years of age. Women with an SBP between 110 and 130 mm Hg at attained ages of 65, 70, 75, and 80 years had a 38% (95% CI, 34%-48%), 54% (52%-56%), 66% (64%-67%), or 75% (73%-78%) absolute probability to survive to 90 years of age, respectively. The probability of surviving to 90 years of age was lower for greater SBP levels. Women at the attained age of 80 years with 0%, 20%, 40%, 60%, 80%, or 100% time in therapeutic range (defined as an SBP between 110 and 130 mm Hg) had a 66% (64%-69%), 68% (67%-70%), 71% (69%-72%), 73% (71%-74%), 75% (72%-77%), or 77% (74%-79%) absolute survival probability to 90 years of age. For women &gt;65 years of age with low cardiovascular disease and other chronic disease risk, an SBP level &lt;130 mm Hg was found to be associated with longevity. These findings reinforce current guidelines targeting an SBP target &lt;130 mm Hg in older women.</abstract><cop>United States</cop><pmid>38623761</pmid><doi>10.1161/CIRCULATIONAHA.123.067302</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4636-8698</orcidid><orcidid>https://orcid.org/0000-0003-4352-0914</orcidid><orcidid>https://orcid.org/0000-0002-9532-976X</orcidid><orcidid>https://orcid.org/0009-0005-6335-760X</orcidid><orcidid>https://orcid.org/0000-0002-8482-1353</orcidid><orcidid>https://orcid.org/0000-0001-5130-6374</orcidid><orcidid>https://orcid.org/0000-0001-6109-431X</orcidid><orcidid>https://orcid.org/0000-0002-0284-6996</orcidid><orcidid>https://orcid.org/0000-0001-6790-0220</orcidid><orcidid>https://orcid.org/0000-0002-9426-7595</orcidid><orcidid>https://orcid.org/0000-0002-6669-5242</orcidid><orcidid>https://orcid.org/0000-0002-2819-2839</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2024-05, Vol.149 (20), p.1568-1577
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_3039806025
source American Heart Association Journals; Journals@Ovid Complete
title Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A37%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systolic%20Blood%20Pressure%20and%20Survival%20to%20Very%20Old%20Age:%20Results%20From%20the%20Women's%20Health%20Initiative&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Haring,%20Bernhard&rft.date=2024-05-14&rft.volume=149&rft.issue=20&rft.spage=1568&rft.epage=1577&rft.pages=1568-1577&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.123.067302&rft_dat=%3Cproquest_cross%3E3039806025%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3039806025&rft_id=info:pmid/38623761&rfr_iscdi=true